These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11513198)

  • 1. Severe hepatotoxicity with jaundice associated with paroxetine.
    Odeh M; Misselevech I; Boss JH; Oliven A
    Am J Gastroenterol; 2001 Aug; 96(8):2494-6. PubMed ID: 11513198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatotoxicity induced by paroxetine].
    Guzmán Ruiz O; Ramírez Martín del Campo M; Fernandez López I; Romero Gómez M
    Med Clin (Barc); 2005 Mar; 124(10):399. PubMed ID: 15766517
    [No Abstract]   [Full Text] [Related]  

  • 3. Reversible hepatotoxicity of paroxetine in a patient with major depression.
    Helmchen C; Boerner RJ; Meyendorf R; Hegerl U
    Pharmacopsychiatry; 1996 Nov; 29(6):223-6. PubMed ID: 8956353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrium and paroxetine-related severe hepatitis.
    Cadranel JF; Di Martino V; Cazier A; Pras V; Bachmeyer C; Olympio P; Gonzenbach A; Mofredj A; Coutarel P; Devergie B; Biour M
    J Clin Gastroenterol; 1999 Jan; 28(1):52-5. PubMed ID: 9916669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute hepatitis associated with use of paroxetine.
    Pompili M; Tittoto P; Mascianà R; Gasbarrini G; Rapaccini GL
    Intern Emerg Med; 2008 Sep; 3(3):275-7. PubMed ID: 18265937
    [No Abstract]   [Full Text] [Related]  

  • 6. Toxic hepatitis associated with paroxetine.
    Colakoglu O; Tankurt E; Unsal B; Ugur F; Kupelioglu A; Buyrac Z; Akpinar Z
    Int J Clin Pract; 2005 Jul; 59(7):861-2. PubMed ID: 15963219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sertraline hepatotoxicity: report of a case and review of the literature.
    Tabak F; Gunduz F; Tahan V; Tabak O; Ozaras R
    Dig Dis Sci; 2009 Jul; 54(7):1589-91. PubMed ID: 18958618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolution of Brugada-pattern ECG after withdrawal of the selective serotonin reuptake inhibitor paroxetine.
    Sawhney V; Thomas G; Webster P; Schilling R
    Heart; 2010 Jul; 96(14):1165-6. PubMed ID: 20478856
    [No Abstract]   [Full Text] [Related]  

  • 9. Perinatal outcome following third trimester exposure to paroxetine.
    Costei AM; Kozer E; Ho T; Ito S; Koren G
    Arch Pediatr Adolesc Med; 2002 Nov; 156(11):1129-32. PubMed ID: 12413342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Serotonin syndrome associated to the use of paroxetine. Case report].
    Cavallazzi LO; Grezesiuk AK
    Arq Neuropsiquiatr; 1999 Sep; 57(3B):886-9. PubMed ID: 10751931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rare case of serotonin syndrome with therapeutic doses of paroxetine.
    Paruchuri P; Godkar D; Anandacoomarswamy D; Sheth K; Niranjan S
    Am J Ther; 2006; 13(6):550-2. PubMed ID: 17122538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of galactorrhea during paroxetine treatment.
    Evrensel A; Önen Ünsalver B; Akyol A; Ceylan ME
    Int J Psychiatry Med; 2016 Apr; 51(3):302-5. PubMed ID: 27284122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of the rabbit syndrome following coadministration of paroxetine, perphenazine, and amitriptyline.
    Gourzis P; Polychronopoulos P; Argyriou AA; Bakalidou C; Beratis S
    Clin Neuropharmacol; 2004; 27(6):299-300. PubMed ID: 15613935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Severe withdrawal symptoms with fever upon stopping paroxetine].
    Vergouwen AC; Kuipers T
    Ned Tijdschr Geneeskd; 1999 Aug; 143(35):1794-5; author reply 1795-6. PubMed ID: 10494332
    [No Abstract]   [Full Text] [Related]  

  • 15. Discontinuing paroxetine: a personal account.
    Shoenberger D
    Psychother Psychosom; 2002; 71(4):237-8. PubMed ID: 12097790
    [No Abstract]   [Full Text] [Related]  

  • 16. A Case Report of Serotonin Syndrome in a Patient on Selective Serotonin Reuptake Inhibitor (SSRI) Monotherapy.
    Hudd TR; Blake CS; Rimola-Dejesus Y; Nguyen TT; Zaiken K
    J Pharm Pract; 2020 Apr; 33(2):206-212. PubMed ID: 31030620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective serotonin reuptake inhibitors and risk for major congenital anomalies.
    Malm H; Artama M; Gissler M; Ritvanen A
    Obstet Gynecol; 2011 Jul; 118(1):111-120. PubMed ID: 21646927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serotonin toxicity caused by moclobemide too soon after paroxetine-selegiline.
    Wu ML; Deng JF
    J Chin Med Assoc; 2009 Aug; 72(8):446-9. PubMed ID: 19687003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Paroxetine and galactorrhea.
    Bonin B; Vandel P; Sechter D; Bizouard P
    Pharmacopsychiatry; 1997 Jul; 30(4):133-4. PubMed ID: 9271780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative delirium indicating an adverse drug interaction involving the selective serotonin reuptake inhibitor, paroxetine?
    Stanford BJ; Stanford SC
    J Psychopharmacol; 1999; 13(3):313-7. PubMed ID: 10512094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.